Abstract
Approximately one-half of all deaths in patients with coronary artery disease occur suddenly and unexpectedly. The majority of these events appear to result from ventricular tachycardia or fibrillation. Although acute ischemia or infarction may precipitate such events, data suggest that a large proportion of these are not due to acute ischemic events. Rather, primary electrical phenomena that are a consequence of previous myocardial infarctions, such as intramyocardial reentry or other mechanisms, cause most of these events. These events usually occur without any apparent precipitating factor. While we have effective treatment for survivors of cardiac arrest, a minority of arrest victims survive the acute event. Thus, there is a need to identify patients at risk for these events before they occur, in order to institute prophylactic therapy.
Multiple tests to identify persons at risk for sudden death have been developed. No single test has been identified that has adequate sensitivity and specificity, when used by itself, because no test identifies patients at risk for all the various mechanisms that can cause sudden death. Increasing evidence suggests that the presence of multiple risk factors in an individual identifies persons at increased risk, while patients with only single risk factors, regardless of the specific factor, are at relatively low risk. However, at this time, the optimal combination of risk factors is not known. Also unknown is the optimal time for initial and repeat testing. Because of the progressive nature of coronary artery disease, tests will have to be repeated at intervals in patients with initial negative tests. Clinical trials are needed to define the best timing and combinations of tests.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Graham I, Mulcahy R, Hickey N, O’Neill W, Daly L. Natural history of coronary heart disease: a study of 586 men surviving an initial acute attack. Am Heart J. 1983;105:249–57.
Zheng Z-J, Croft JB, Giles WH, Mensah GA. Sudden cardiac death in the united states, 1989 to 1998. Circulation. 2001;104:2158–63.
Pouleur AC, Barkoudah E, Uno H, Skali H, Finn PV, Zelenkofske SL, et al. Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. Circulation. 2010;122:597–602.
Baum R, Alvarez H, Cobb LA. Survival after resuscitation from out-of-hospital ventricular fibrillation. Circulation. 1974;50:1231–5.
Becker LB, Han BH, Meyer PM, Wright FA, Rhodes KV, Smith DW, et al. Racial differences in the incidence of cardiac arrest and subsequent survival. The CPR Chicago Project. N Engl J Med. 1993;329:600–6.
Eisenberg MS, Hallstrom A, Bergner L. Long-term survival after out-of-hospital cardiac arrest. N Engl J Med. 1982;306:1340–3.
Liberthson RR, Nagel EL, Hirschman JC, Nussenfeld SR. Prehospital ventricular defibrillation. Prognosis and follow-up course. N Engl J Med. 1974;291:317–21.
Myerburg RJ, Fenster J, Velez M, Rosenberg D, Lai S, Kurlansky P, et al. Impact of community-wide police car deployment of automated external defibrillators on survival from out-of-hospital cardiac arrest. Circulation. 2002;106:1058–64.
Weaver WD, Hill D, Fahrenbruch CE, Copass MK, Martin JS, Cobb LA, et al. Use of the automatic external defibrillator in the management of out-of-hospital cardiac arrest. N Engl J Med. 1988;319:661–6.
Holmes DRJ, Davis KB, Mock MB, Fisher LD, Gersh BJ, Killip T, et al. Study PitCAS. The effect of medical and surgical treatment on subsequent sudden cardiac death in patients with coronary artery disease. A report from the Coronary Artery Surgery Study. Circulation. 1986;73:1254–63.
Huikuri HV, Tapanainen JM, Lindgren K, Raatikainen P, Makikallio TH, Airaksinen KEJ, et al. Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era. J Am Coll Cardiol. 2003;42:652–8.
Tavazzi L, Volpi A, Investigators G. Remarks about postinfarction prognosis in light of the experience with the gruppo italiano per lo studio della sopravvivenza nell’ infarto miocardico (gissi) trials. Circulation. 1997;95:1341–5.
Madsen EB, Gilpin E, Henning H. Evaluation of prognosis one year after myocardial infarction. J Am Coll Cardiol. 1983;1:985–93.
Rouleau JL, Talajic M, Sussex B, Potvin L, Warnica W, Davies RF, et al. Myocardial infarction patients in the 1990s – their risk factors, stratification and survival in Canada: the Canadian Assessment of Myocardial Infarction (CAMI) Study. J Am Coll Cardiol. 1996;27:1119–27.
Sanz G, Castaner A, Betriu A, Magrina J, Roig E, Coll S, et al. Determinants of prognosis in survivors of myocardial infarction. A prospective clinical angiographic study. N Engl J Med. 1982;306:1065–70.
Weinberg SL. Natural history six years after acute myocardial infarction. Is there a low risk group? Chest. 1976;69:23–8.
Fioretti P, Brower RW, Simoons ML, ten Katen H, Beelen A, Baardman T, et al. Relative value of clinical variables, bicycle ergometry, rest radionuclide ventriculography and 24 hour ambulatory electrocardiographic monitoring at discharge to predict 1 year survival after myocardial infarction. J Am Coll Cardiol. 1986;8:40–9.
Mazzoleni A, Curtin ME, Wolff R, Reiner L, Somes G. On the relationship between heart weights, fibrosis, and QRS duration. J Electrocardiol. 1975;8:233–6.
Zimetbaum PJ, Buxton AE, Batsford W, Fisher JD, Hafley GE, Lee KL, et al. Electrocardiographic predictors of arrhythmic death and total mortality in the multicenter unsustained tachycardia trial. Circulation. 2004;110:766–9.
Greenberg H, Case RB, Moss AJ, Brown MW, Carroll ER, Andrews ML, et al. Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II). J Am Coll Cardiol. 2004;43:1459–65.
Buxton A, Lee K, Hafley G, Pires L, Fisher J, Gold M, et al. Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease. Lessons from the MUSTT study. J Am Coll Cardiol. 2007;50:1150–7.
Levy WC, Lee K, Hellkamp A, Poole JE, Mazaffarian D, Linker DT, et al. Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population. Circulation. 2009;120:835–42.
Buxton AE, Sweeney MO, Wathen MS, Josephson ME, Otterness MF, Hogan-Miller E, et al. Qrs duration does not predict occurrence of ventricular tachyarrhythmias in patients with implanted cardioverter-defibrillators. J Am Coll Cardiol. 2005;46:310–6.
Schechtman KB, Capone RJ, Kleiger RE, Gibson RS, Schwartz DJ, Roberts R, et al. Risk stratification of patients with non-Q wave myocardial infarction. The critical role of ST segment depression. The Diltiazem Reinfarction Study Research Group. Circulation. 1989;80:1148–58.
Cannon CP, McCabe CH, Stone PH, Rogers WJ, Schactman M, Thompson BW, et al. The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: results of the TIMI III Registry ECG Ancillary Study. J Am Coll Cardiol. 1997;30:133–40.
Davey P. Qt interval and mortality from coronary artery disease. Prog Cardiovasc Dis. 2000;42:359–84.
Algra A, Tijssen J, Roelandt J, Pool J, Lubsen J. QTc prolongation measured by standard 12-lead electrocardiography is an independent risk factor for sudden death due to cardiac arrest. Circulation. 1991;83:1888–94.
Dekker JM, Schouten EG, Klootwijk P, Pool J, Kromhout D. Association between QT interval and coronary heart disease in middle-aged and elderly men. The Zutphen Study. Circulation. 1994;90:779–85.
Straus SM, Kors JA, De Bruin ML, van der Hooft CS, Hofman A, Heeringa J, et al. Prolonged QTC interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol. 2006;47:362–7.
de Bruyne MC, Hoes AW, Kors JA, Hofman A, van Bemmel JH, Grobbee DE. Prolonged QT interval predicts cardiac and all-cause mortality in the elderly. The Rotterdam Study. Eur Heart J. 1999;20:278–84.
Zhang Y, Post W, Blasco-Colmenares E, Dalal D, Tomaselli G, Guallara E. Electrocardiographic QT interval and mortality. A meta-analysis. Epidemiology. 2011;22:660–70.
Statters DJ, Malik M, Ward DE, Camm AJ. QT dispersion: problems of methodology and clinical significance. J Cardiovasc Electrophysiol. 1994;5:672–85.
Zabel M, Klingenheben T, Franz MR, Hohnloser SH. Assessment of QT dispersion for prediction of mortality or arrhythmic events after myocardial infarction: results of a prospective, long-term follow-up study. Circulation. 1998;97:2543–50.
Zabel M, Acar B, Klingenheben T, Franz MR, Hohnloser SH, Malik M. Analysis of 12-lead T-wave morphology for risk stratification after myocardial infarction. Circulation. 2000;102:1252–7.
Savelieva I, Yap YG, Yi G, Guo X, Camm AJ, Malik M. Comparative reproducibility of QT, QT peak, and T peak-T end intervals and dispersion in normal subjects, patients with myocardial infarction, and patients with hypertrophic cardiomyopathy. Pacing Clin Electrophysiol. 1998;21:2376–81.
Panikkath R, Reinier K, Uy-Evanado A, Teodorescu C, Hattenhauer J, Mariani R, et al. Prolonged tpeak to tend interval on the resting electrocardiogram is associated with increased risk of sudden cardiac death. Circulation. 2011;4:441–7.
Westaway S, Reinier K, Huertas-Vasquez A, Evanado A, Teodorescu C, Navarro J, et al. Common variants in CASQ2, GPD1L, and NOS1AP are significantly associated with risk of sudden death in patients with coronary artery disease. Circ Cardiovasc Genet. 2011;4:397–402.
Kannel W, Doyle J, McNamara P, Quickenton P, Gordon T. Precursors of sudden coronary death: factors related to the incidence of sudden death. Circulation. 1975;51:606–13.
Siscovick D, Raghunathan T, Rautaharju P, Psaty B, Cobb L, Wagner E. Clinically silent electrocardiographic abnormalities and risk of primary cardiac arrest among hypertensive patients. Circulation. 1996;94:1329–33.
Westerhout C, Lauer M, James S, Fu Y, Wallentin L, Armstrong P. Electrocardiographic left ventricular hypertrophy in GUSTO IV ACS: an important risk marker of mortality in women. Eur Heart J. 2007;28:2064–9.
Nelson GR, Cohn PF, Gorlin R. Prognosis in medically-treated coronary artery disease. Influence of ejection fraction compared to other parameters. Circulation. 1975;52:408–12.
Schulze RA, Strauss HW, Pitt B. Sudden death in the year following myocardial infarction. Relation to ventricular premature contractions in the late hospital phase and left ventricular ejection fraction. Am J Med. 1977;62:192–9.
Maggioni AP, Zuanetti G, Franzosi MG, Rovelli F, Santoro E, Staszewsky L, et al. Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 results. Circulation. 1993;87:312–22.
Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G, et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med. 1999;341:1882–90.
Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877–83.
Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225–37.
Bailey JJ, Berson AS, Handelsman H, Hodges M. Utility of current risk stratification tests for predicting major arrhythmic events after myocardial infarction. J Am Coll Cardiol. 2001;38:1902–11.
Buxton A, Hafley G, Lee K, Gold M, Packer D, Lehmann M, et al. Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease. Circulation. 2002;106:2466–72.
Curtis J, Sokol S, Wang Y, Rathore S, Ko D, Jadbabaie F, et al. The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure. J Am Coll Cardiol. 1983;42:736–42.
Ross AM, Coyne KS, Moreyra E, Reiner JS, Greenhouse SW, Walker PL, et al. Extended mortality benefit of early postinfarction reperfusion. Circulation. 1998;97:1549–56.
Gorgels A, Gijsbers C, de Vreede-Swagemakers J, Lousberg A, Wellens H. Out-of-hospital cardiac arrest-the relevance of heart failure. The Maastricht Circulatory Arrest Registry. Eur Heart J. 2003;24:1204–9.
Shiga T, Hagiwara N, Ogawa H, Takagi A, Nagashima M, Yamauchi T, et al. Sudden cardiac death and left ventricular ejection fraction during long-term follow-up after acute myocardial infarction in the primary percutaneous coronary intervention era: results from the HIJAMI-II registry. Heart. 2009;95:216–20.
Copie X, Hnatkova K, Staunton A, Fei L, Camm A, Malik M. Predictive power of increased heart rate versus depressed left ventricular ejection fraction and heart rate variability for risk stratification after myocardial infarction. Results of a two-year follow-up study. J Am Coll Cardiol. 1996;27:270–6.
Hare JL, Brown JK, Marwick TH. Performance of conventional echocardiographic parameters and myocardial measurements in the sequential evaluation of left ventricular function. Am J Cardiol. 2008;101:706–11.
Exner DV, Kavanagh KM, Slawnych MP, Mitchell LB, Ramadan D, Aggarwal SG, et al. Noninvasive risk assessment early after a myocardial infarction: The REFINE study. J Am Coll Cardiol. 2007;50:2275–84.
Anderson KP, DeCamilla J, Moss AJ. Clinical significance of ventricular tachycardia (3 beats or longer) detected during ambulatory monitoring after myocardial infarction. Circulation. 1978;57:890–7.
Bigger JT, Weld FM, Rolnitzky LM. Prevalence, characteristics and significance of ventricular tachycardia (three or more complexes) detected with ambulatory electrocardiographic recording in the late hospital phase of acute myocardial infarction. Am J Cardiol. 1981;48:815–23.
Ruberman W, Weinblatt E, Goldberg JD, Frank CW, Shapiro S. Ventricular premature complexes and mortality after myocardial infarction. N Engl J Med. 1977;297:750–5.
Hallstrom AP, Bigger JT, Roden D, Friedman L, Akiyama T, Richardson DW, et al. Prognostic significance of ventricular premature depolarizations measured 1 year after myocardial infarction in patients with early postinfarction asymptomatic ventricular arrhythmia. J Am Coll Cardiol. 1992;20:259–64.
Tominaga S, Blackburn H, Group CDPR. Prognostic importance of premature beats following myocardial infarction: experience in the coronary drug project. JAMA. 1973;223:1116–24.
Huikuri HK, Mahaux V, Bloch Thomsen P-E, CARISMA Investigators. Cardiac arrhythmias and risk stratification after myocardial infarction: results of the CARISMA pilot study. Pacing Clin Electrophysiol. 2003;26:416–9.
Hohnloser SH, Klingenheben T, Zabel M, Schopperl M, Mauss O. Prevalence, characteristics and prognostic value during long-term follow-up of nonsustained ventricular tachycardia after myocardial infarction in the thrombolytic era. J Am Coll Cardiol. 1999;33:1895–902.
Makikallio TH, Barthel P, Schneider R, Bauer A, Tapanainen JM, Tulppo MP, et al. Prediction of sudden cardiac death after acute myocardial infarction: role of holter monitoring in the modern treatment era. Eur Heart J. 2005;26:762–9.
Scirica BM, Braunwald E, Belardinelli L, Hedgepeth CM, Spinar J, Wang W, et al. Relationship between nonsustained ventricular tachycardia after non-ST-elevation acute coronary syndrome and sudden cardiac death: observations from the metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndrome-thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36) randomized controlled trial. Circulation. 2010;122:455–62.
Breithardt G, Schwarzmaier J, Borggrefe M, Haerten K, Seipel L. Prognostic significance of late ventricular potentials after acute myocardial infarction. Eur Heart J. 1983;4:487–95.
Gomes JA, Winters SL, Stewart D, Horowitz S, Milner M, Barreca P. A new noninvasive index to predict sustained ventricular tachycardia and sudden death in the first year after myocardial infarction: based on signal-averaged electrocardiogram, radionuclide ejection fraction and holter monitoring. J Am Coll Cardiol. 1987;10:349–57.
Steinberg JS, Regan A, Sciacca RR, Bigger JT, Fleiss JL, Salvatore DE, et al. Predicting arrhythmic events after acute myocardial infarction using the signal-averaged electrocardiogram. Am J Cardiol. 1992;69:13–21.
Kuchar DL, Thorburn CW, Sammel NL. Prediction of serious arrhythmic events after myocardial infarction: signal-averaged electrocardiogram, holter monitoring and radionuclide ventriculography. J Am Coll Cardiol. 1987;9:531–8.
El-Sherif N, Denes P, Katz R, Capone R, Mitchell LB, Carlson M, et al. Definition of the best prediction criteria of the time domain signal-averaged electrocardiogram for serious arrhythmic events in the postinfarction period. J Am Coll Cardiol. 1995;25:908–14.
Gomes J, Cain M, Buxton A, Josephson M, Lee K, Hafley G. Prediction of long-term outcomes by signal-averaged electrocardiography in patients with unsustained ventricular tachycardia, coronary artery disease, and left ventricular dysfunction. Circulation. 2001;104:436–41.
Hood MA, Pogwizd SM, Peirick J, Cain ME. Contribution of myocardium responsible for ventricular tachycardia to abnormalities detected by analysis of signal-averaged ECGs. Circulation. 1992;86:1888–901.
Scharf C, Redecker H, Duru F, Candinas R, Brunner-La Rocca HP, Gerber A, et al. Sudden cardiac death after coronary artery bypass grafting is not predicted by signal-averaged ECG. Ann Thorac Surg. 2001;72:1546–51.
Gang ES, Lew AS, Hong M, Wang FZ, Siebert CA, Peter T. Decreased incidence of ventricular late potentials after successful thrombolytic therapy for acute myocardial infarction. N Engl J Med. 1989;321:712–6.
Pedretti R, Laporta A, Etro MD, Gementi A, Bonelli R, Anza C, et al. Influence of thrombolysis on signal-averaged electrocardiogram and late arrhythmic events after acute myocardial infarction. Am J Cardiol. 1992;69:866–72.
Zimmermann M, Adamec R, Ciaroni S. Reduction in the frequency of ventricular late potentials after acute myocardial infarction by early thrombolytic therapy. Am J Cardiol. 1991;67:697–703.
Hohnloser SH, Franck P, Klingenheben T, Zabel M, Just H. Open infarct artery, late potentials, and other prognostic factors in patients after acute myocardial infarction in the thrombolytic era. A prospective trial. Circulation. 1994;90:1747–56.
Vatterott PJ, Hammill SC, Bailey KR, Wiltgen CM, Gersh BJ. Late potentials on signal-averaged electrocardiograms and patency of the infarct-related artery in survivors of acute myocardial infarction. J Am Coll Cardiol. 1991;17:330–7.
Buxton A, Waxman H, Marchlinski F, Untereker W, Waspe L, Josephson M. Role of triple extrastimuli during electrophysiologic study of patients with documented sustained ventricular tachyarrhythmias. Circulation. 1984;69:532–40.
Ruskin J, DiMarco J, Garan H. Out-of-hospital cardiac arrest: electrophysiologic observations and selection of long-term antiarrhythmic therapy. N Engl J Med. 1980;303:607–13.
Josephson M, Horowitz L, Spielman S, Greenspan A. Electrophysiologic and hemodynamic studies in patients resuscitated from cardiac arrest. Am J Cardiol. 1980;46:948–55.
Greene H, Reid P, Schaeffer A. The repetitive ventricular response in man – a predictor of sudden death. N Engl J Med. 1978;299:729–34.
Hamer A, Vohra J, Hunt D, Sloman G. Prediction of sudden death by electrophysiologic studies in high risk patients surviving acute myocardial infarction. Am J Cardiol. 1982;50:223–9.
Richards D, Cody D, Denniss A, Russell P, Young A, Uther J. Ventricular electrical instability: a predictor of death after myocardial infarction. Am J Cardiol. 1983;51:75–80.
Marchlinski F, Buxton A, Waxman H, Josephson M. Identifying patients at risk of sudden death after myocardial infarction: value of the response to programmed stimulation, degree of ventricular ectopic activity and severity of left ventricular dysfunction. Am J Cardiol. 1983;52:1190–6.
Roy D, Marchand E, Theroux P, Waters DD, Pelletier GB, Bourassa MG. Programmed ventricular stimulation in survivors of an acute myocardial infarction. Circulation. 1985;72:487–94.
Waspe L, Seinfeld D, Ferrick A, Kim S, Matos J, Fisher J. Prediction of sudden death and spontaneous ventricular tachycardia in survivors of complicated myocardial infarction: value of the response to programmed stimulation using a maximum of three ventricular extrastimuli. J Am Coll Cardiol. 1985;5:1292–301.
Bhandari AK, Rose JS, Kotlewski A, Rahimtoola SH, Wu D. Frequency and significance of induced sustained ventricular tachycardia or fibrillation two weeks after acute myocardial infarction. Am J Cardiol. 1985;56:737–42.
Iesaka Y, Nogami A, Aonuma K, Nitta J, Chun YH, Fujiwara H, et al. Prognostic significance of sustained monomorphic ventricular tachycardia induced by programmed ventricular stimulation using up to triple extrastimuli in survivors of acute myocardial infarction. Am J Cardiol. 1990;65:1057–63.
Buxton AE, Lee KL, DiCarlo L, Gold MR, Greer GS, Prystowsky EN, et al. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. N Engl J Med. 2000;342:1937–45.
Daubert J, Zareba W, Hall W, Schuger C, Corsello A, Leon AR, et al. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. J Am Coll Cardiol. 2006;47:98–107.
Roy D, Marchand E, Theroux P, Waters DD, Pelletier GB, Cartier R, et al. Long-term reproducibility and significance of provokable ventricular arrhythmias after myocardial infarction. J Am Coll Cardiol. 1986;8:32–9.
Bourke JP, Richards DA, Ross DL, Wallace EM, McGuire MA, Uther JB. Routine programmed electrical stimulation in survivors of acute myocardial infarction for prediction of spontaneous ventricular tachyarrhythmias during follow-up: results, optimal stimulation protocol and cost-effective screening. J Am Coll Cardiol. 1991;18:780–8.
Kumar S, Sivagangabalan G, Zaman S, West EB, Narayan A, Thiagalingam A, et al. ElectroÂphysiology-guided defibrillator implantation early after ST-elevation myocardial infarction. Heart Rhythm. 2010;7:1589–97.
Bourke J, Richards D, Ross D, McGuire M, Uther J. Does the induction of ventricular flutter or fibrillation at electrophysiologic testing after myocardial infarction have any prognostic significance? Am J Cardiol. 1995;75:431–5.
Josephson ME, Almendral JM, Buxton AE, Marchlinski FE. Mechanisms of ventricular tachycardia. Circulation. 1987;75:III41–7.
Kuck KH, Costard A, Schluter M, Kunze KP. Significance of timing programmed electrical stimulation after acute myocardial infarction. J Am Coll Cardiol. 1986;8:1279–88.
Bhandari AK, Au PK, Rose JS, Kotlewski A, Blue S, Rahimtoola SH. Decline in inducibility of sustained ventricular tachycardia from two to twenty weeks after acute myocardial infarction. Am J Cardiol. 1987;59:284–90.
Bhandari AK, Hong R, Kulick D, Petersen R, Rubin JN, Leon C, et al. Day to day reproducibility of electrically inducible ventricular arrhythmias in survivors of acute myocardial infarction. J Am Coll Cardiol. 1990;15:1075–81.
Nogami A, Aonuma K, Takahashi A, Nitta J, Chun YH, Iesaka Y, et al. Usefulness of early versus late programmed ventricular stimulation in acute myocardial infarction. Am J Cardiol. 1991;68:13–20.
Gomes JA, Hariman RI, Kang PS, El-Sherif N, Chowdhry I, Lyons J. Programmed electrical stimulation in patients with high-grade ventricular ectopy: electrophysiologic findings and prognosis for survival. Circulation. 1984;70:43–51.
Buxton AE, Marchlinski FE, Flores BT, Miller JM, Doherty JU, Josephson ME. Nonsustained ventricular tachycardia in patients with coronary artery disease: role of electrophysiologic study. Circulation. 1987;75:1178–85.
Klein RC, Machell C. Use of electrophysiologic testing in patients with nonsustained ventricular tachycardia: prognostic and therapeutic implications. J Am Coll Cardiol. 1989;14:155–61.
Wilber DJ, Olshansky B, Moran JF, Scanlon PJ. Electrophysiological testing and nonsustained ventricular tachycardia. Use and limitations in patients with coronary artery disease and impaired ventricular function. Circulation. 1990;82:350–8.
Kersschot I, Brugada P, Ramentol M, Zehender M, Waldecker B, Stevenson W, et al. Effects of early reperfusion in acute myocardial infarction on arrhythmias induced by programmed stimulation: a prospective, randomized study. J Am Coll Cardiol. 1986;7:1234–42.
Bourke J, Young A, Richards D, Uther J. Reduction in incidence of inducible ventricular tachycardia after myocardial infarction by treatment with streptokinase during infarct evolution. J Am Coll Cardiol. 1990;16:1703–10.
Chong JJ, Ganesan AN, Eipper V, Kovoor P. Comparison of left ventricular ejection fraction and inducible ventricular tachycardia in ST-elevation myocardial infarction treated by primary angioplasty versus thrombolysis. Am J Cardiol. 2008;101:153–7.
Armoundas AA, Tomaselli GF, Esperer HD. Pathophysiological basis and clinical application of T-wave alternans. J Am Coll Cardiol. 2002;40:207–17.
Walker M, Rosenbaum D. Repolarization Âalternans: implications for the mechanism and prevention of sudden cardiac death. Cardiovasc Res. 2003;57:599–614.
Rashba EJ, Osman AF, MacMurdy K, Kirk MM, Sarang S, Peters RW, et al. Exercise is superior to pacing for T wave alternans measurement in subjects with chronic coronary artery disease and left ventricular dysfunction. J Cardiovasc Electrophysiol. 2002;13:845–50.
Nearing BD, Verrier RL. Modified moving average analysis of T-wave alternans to predict ventricular fibrillation with high accuracy. J Appl Physiol. 2002;92:541–9.
Verrier RL, Klingenheben T, Malik M, El-Sherif N, Exner DV, Hohnloser SH, et al. Microvolt T-wave alternans physiological basis, methods of measurement, and clinical utility – consensus guideline by International Society for Holter and Noninvasive Electrocardiology. J Am Coll Cardiol. 2011;58:1309–24.
Gold MR, Bloomfield DM, Anderson KP, El-Sherif NE, Wilber DJ, Groh WJ, et al. A comparison of T-wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification. J Am Coll Cardiol. 2000;36:2247–53.
Hohnloser SH, Klingenheben T, Bloomfield D, Dabbous O, Cohen RJ. Usefulness of microvolt T-wave alternans for prediction of ventricular tachyarrhythmic events in patients with dilated cardiomyopathy: results from a prospective observational study. J Am Coll Cardiol. 2003;41:2220–4.
Klingenheben T, Zabel M, D’Agostino RB, Cohen RJ, Hohnloser SH. Predictive value of T-wave alternans for arrhythmic events in patients with congestive heart failure. Lancet. 2000;356:651–2.
Rashba EJ, Osman AF, Macmurdy K, Kirk MM, Sarang SE, Peters RW, et al. Enhanced detection of arrhythmia vulnerability using T wave alternans, left ventricular ejection fraction, and programmed ventricular stimulation: a prospective study in subjects with chronic ischemic heart disease. J Cardiovasc Electrophysiol. 2004;15:170–6.
Rosenbaum DS, Jackson LE, Smith JM, Garan H, Ruskin JN, Cohen RJ. Electrical alternans and vulnerability to ventricular arrhythmias. N Engl J Med. 1994;330:235–41.
Tanno K, Ryu S, Watanabe N, Minoura Y, Kawamura M, Asano T, et al. Microvolt T-wave alternans as a predictor of ventricular tachyarrhythmias: a prospective study using atrial Âpacing. Circulation. 2004;109:1854–8.
Bloomfield DM, Bigger JT, Steinman RC, Namerow PB, Parides MK, Curtis AB, et al. Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol. 2006;47:456–63.
Gehi AK, Stein RH, Metz LD, Gomes JA. Microvolt T-wave alternans for the risk stratification of ventricular tachyarrhythmic events: a meta-analysis. J Am Coll Cardiol. 2005;46:75–82.
Costantini O, Hohnloser SH, Kirk MM, Lerman BB, Baker JH, Sethuraman B, et al. The ABCD (alternans before cardioverter defibrillator) trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention. J Am Coll Cardiol. 2009;53:471–9.
Gold MR, Ip JH, Costantini O, Poole JE, McNulty S, Mark DB, et al. Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy. Circulation. 2008;118:2022–8.
Chow T, Kereiakes DJ, Onufer J, Woelfel A, Gursoy S, Peterson BJ, et al. Does microvolt T-wave alternans testing predict ventricular tachyarrhythmias in patients with ischemic cardiomyopathy and prophylactic defibrillators? The MASTER (Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients) trial. J Am Coll Cardiol. 2008;52:1607–15.
Ikeda T, Yoshino H, Sugi K, Tanno K, Shimizu H, Watanabe J, et al. Predictive value of microvolt T-wave alternans for sudden cardiac death in patients with preserved cardiac function after acute myocardial infarction: results of a collaborative cohort stud. J Am Coll Cardiol. 2006;48:2268–74.
Bloomfield DM, Steinman RC, Namerow PB, Parides M, Davidenko J, Kaufman ES, et al. Microvolt T-wave alternans distinguishes betÂween patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum. Circulation. 2004;110:1885–9.
Chow T, Kereiakes DJ, Bartone C, Booth T, Schloss EJ, Waller T, et al. Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy. J Am Coll Cardiol. 2006;47:1820–7.
Tapanainen JM, Still AM, Airaksinen KE, Huikuri HV. Prognostic significance of risk stratifiers of mortality, including T wave alternans, after acute myocardial infarction: results of a prospective follow-up study. J Cardiovasc Electrophysiol. 2001;12:645–52.
Force T. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation. 1996;93:1043–65.
Zuanetti G, Latini R, Neilson JM, Schwartz PJ, Ewing DJ. Heart rate variability in patients with ventricular arrhythmias: effect of antiarrhythmic drugs. Antiarrhythmic Drug Evaluation Group (ADEG). J Am Coll Cardiol. 1991;17:604–12.
Kontopoulos AG, Athyros VG, Papageorgiou AA, Papadopoulos GV, Avramidis MJ, Boudoulas H. Effect of quinapril or metoprolol on heart rate variability in post-myocardial infarction patients. Am J Cardiol. 1996;77:242–6.
Kleiger RE, Miller JP, Bigger Jr JT, Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol. 1987;59:256–62.
Tsuji H, Venditti Jr FJ, Manders ES, Evans JC, Larson MG, Feldman CL, et al. Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study. Circulation. 1994;90:878–83.
La Rovere MT, Bigger Jr JT, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet. 1998;351:478–84.
La Rovere MT, Pinna GD, Hohnloser SH, Marcus FI, Mortara A, Nohara R, et al. Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials. Circulation. 2001;103:2072–7.
Huikuri HV, Makikallio TH, Peng CK, Goldberger AL, Hintze U, Moller M. Fractal correlation properties of R-R interval dynamics and mortality in patients with depressed left ventricular function after an acute myocardial infarction. Circulation. 2000;101:47–53.
Camm AJ, Pratt CM, Schwartz PJ, Al-Khalidi HR, Spyt MJ, Holroyde MJ, et al. Mortality in patients after a recent myocardial infarction: a randomized, placebo-controlled trial of azimilide using heart rate variability for risk stratification. Circulation. 2004;109:990–6.
Casolo GC, Stroder P, Signorini C, Calzolari F, Zucchini M, Balli E, et al. Heart rate variability during the acute phase of myocardial infarction. Circulation. 1992;85:2073–9.
Kuch B, Parvanov T, Hense HW, Axmann J, Bolte HD. Short-period heart rate variability in the general population as compared to patients with acute myocardial infarction from the same source population. Ann Noninvasive ElectroÂcardiol. 2004;9:113–20.
Lakusic N, Smalcelj A, Mahovic D, Puljevic D, Lovric-Bencic M. Heart rate variability differences in post-myocardial infarction patients based on initial treatment during acute phase of disease. Int J Cardiol. 2008;126:437–8.
La Rovere MT, Pinna GD, Maestri R, Mortara A, Capomolla S, Febo O, et al. Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation. 2003;107:565–70.
La Rovere M, Bigger Jr JT, Marcus F, Mortara A, Schwartz P, for the ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet. 1998;351:478–84.
Bauer A, Kantelhardt JW, Barthel P, Schneider R, Makikallio T, Ulm K, et al. Deceleration capacity of heart rate as a predictor of mortality after myocardial infarction: cohort study. Lancet. 2006;367:1674–81.
Farrell TG, Odemuyiwa O, Bashir Y, Cripps TR, Malik M, Ward DE, et al. Prognostic value of baroreflex sensitivity testing after acute myocardial infarction. Br Heart J. 1992;67:129–37.
Farrell TG, Paul V, Cripps TR, Malik M, Bennett ED, Ward D, et al. Baroreflex sensitivity and electrophysiological correlates in patients after acute myocardial infarction. Circulation. 1991;83:945–52.
De Ferrari GM, Sanzo A, Bertoletti A, Specchia G, Vanoli E, Schwartz PJ. Baroreflex sensitivity predicts long-term cardiovascular mortality after myocardial infarction even in patients with preserved left ventricular function. J Am Coll Cardiol. 2007;50:2285–90.
Bauer A, Malik M, Schmidt G, Barthel P, Bonnemeier H, Cygankiewicz I, et al. Heart rate turbulence: Standards of measurement, physiological interpretation, and clinical use: International Society for Holter and Noninvasive Electrophysiology Consensus. J Am Coll Cardiol. 2008;52:1353–65.
Schmidt G, Malik M, Barthel P, Schneider R, Ulm K, Rolnitzky L, et al. Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction. Lancet. 1999;353:1390–6.
Ghuran A, Reid F, La Rovere MT, Schmidt G, Bigger Jr JT, Camm AJ, et al. Heart rate turbulence-based predictors of fatal and nonfatal cardiac arrest (the autonomic tone and reflexes after myocardial infarction substudy). Am J Cardiol. 2002;89:184–90.
Barthel P, Schneider R, Bauer A, Ulm K, Schmitt C, Schomig A, et al. Risk stratification after acute myocardial infarction by heart rate turbulence. Circulation. 2003;108:1221–6.
Bauer A, Barthel P, Schneider R, Ulm K, Muller A, Joeinig A, et al. Improved Stratification of Autonomic Regulation for risk prediction in post-infarction patients with preserved left ventricular function (ISAR-Risk). Eur Heart J. 2009;30:576–83.
Kwon DH, Smedira NG, Rodriguez ER, Tan C, Setser R, Thamilarasan M, et al. Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia. J Am Coll Cardiol. 2009;54:242–9.
Kwong RY, Chan AK, Brown KA, Chan CW, Reynolds HG, Tsang S, et al. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation. 2006;113:2733–43.
Yan AT, Shayne AJ, Brown KA, Gupta SN, Chan CW, Luu TM, et al. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. CirculaÂtion. 2006;114:32–9.
Schmidt A, Azevedo C, Cheng A, Guptsa S, Bluemke D, Foo T, et al. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation. 2006;115:2006–14.
Boye P, Abdel-Aty H, Zacharzowsky U, Bohl S, Schwenke C, van der Geest RJ, et al. Prediction of life-threatening arrhythmic events in patients with chronic myocardial infarction by contrast-enhanced CMR. JACC Cardiovasc Imaging. 2011;4:871–9.
Ciaccio EJ, Ashikaga H, Kaba RA, Cervantes D, Hopenfeld B, Wit AL, et al. Model of reentrant ventricular tachycardia based on infarct border zone geometry predicts reentrant circuit features as determined by activation mapping. Heart Rhythm. 2007;4:1034–45.
Grothues F, Smith GC, Moon JC, Bellenger NG, Collins P, Klein HU, et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol. 2002;90:29–34.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag London
About this chapter
Cite this chapter
Liu, E.H., Joventino, L.P., Buxton, A.E. (2013). Risk Stratification for Sudden Death in Patients with Coronary Artery Disease. In: Gussak, I., Antzelevitch, C. (eds) Electrical Diseases of the Heart. Springer, London. https://doi.org/10.1007/978-1-4471-4978-1_22
Download citation
DOI: https://doi.org/10.1007/978-1-4471-4978-1_22
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-4977-4
Online ISBN: 978-1-4471-4978-1
eBook Packages: MedicineMedicine (R0)